The Challenge: Inherited a distressed $6MM commodity injection molder bleeding cash, suffering 50% RMA rates, and completely dependent on a single deteriorating customer relationship.
The Strategic Thesis: Made the strategic call to exit unprofitable commodity work and reposition the company as a precision partner. Concurrently restructured the organization, recruiting and aligning a seven-member executive team to execute this vision in regulated markets requiring technical excellence.
The Execution: Led a 120-person operation through a complete cultural transformation. Built the leadership capabilities required to achieve ISO 9001:2015 certification, deployed Lean manufacturing systems, and secured Fortune 500 partnerships. Transformed pricing from a cost-plus model to a value-based structure.